matrix metallopeptidase 9 (R&D Systems)
R&D Systems is a verified supplier 
R&D Systems manufactures this product 
95
Structured Review
R&D Systems
matrix metallopeptidase 9
Matrix Metallopeptidase 9, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 146 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+mmp/Human+MMP-9+DuoSet+ELISA/pmc13054578-81-14-19
Average 95 stars, based on 146 article reviews
Matrix Metallopeptidase 9, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 146 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+mmp/Human+MMP-9+DuoSet+ELISA/pmc13054578-81-14-19
Average 95 stars, based on 146 article reviews
matrix metallopeptidase 9 - by Bioz Stars,
2026-09
95/100 stars
Images
1) Product Images from "The cellular response capacity (CRC) as a novel immunomonitoring approach in sepsis"
Article Title: The cellular response capacity (CRC) as a novel immunomonitoring approach in sepsis
Journal: Military Medical Research
doi: 10.1016/j.mmr.2026.100010
Figure Legend Snippet: Concentration-dependent change in the humoral inflammatory response following incubation with Escherichia coli ( E. coli ) in the ex vivo whole blood model. a Absolute plasma concentrations of IL-6, IL-8, and MMP9 determined by enzyme-linked immunosorbent assay. b Normalized values and EC 50 curve fit by BuC=0% and 50 000 CFU/ml E. coli= 100%, respectively, for IL-6, IL-8, and MMP9 as indicated by EC 50 (%) on the respective Y-axis. BuC indicates buffer control after 60 min incubation; numbers on the X-axis indicate E. coli bacteria in concentrations of 2000 to 50 000 CFU/ml after 60 min incubation; LPS indicates lipopolysaccharide (LPS) 100 ng/ml after 60 min incubation. Values are shown as median and interquartile range. n =8. Statistical analysis was performed using the Kruskal-Wallis test with Dunn’s post-hoc test, comparing all shown concentrations of E. coli bacteria and 100 ng/ml LPS with BuC. P -values are indicated above the respective data points. ⁎ P <0.05, ⁎⁎ P <0.01, ⁎⁎⁎ P <0.001. CFU. Colony-forming units; IL. Interleukin; MMP9. Matrix metallopeptidase 9.
Techniques Used: Concentration Assay, Incubation, Ex Vivo, Clinical Proteomics, Enzyme-linked Immunosorbent Assay, Control, Bacteria
Figure Legend Snippet: Diagnostic performance for the detection of bacteremia, analyzing the neutrophil phenotype by determining the median fluorescence intensity (MFI) and the cellular response capacity (CRC) in comparison with traditional markers of humoral inflammation (IL-6, IL-8, MMP9). a Comparison of receiver operating characteristic (ROC) at 10,000 CFU/ml Escherichia coli ( E. coli ) with the respective 95% confidence interval (CI) and P -value, and half-maximal effective concentration (EC 50 ) as a function of the E. coli concentration. b Detailed comparison of the EC 50 as a function of the E. coli concentration. c Exemplary comparison of EC 50 curve fit after normalization as indicated by EC 50 (%) on the respective Y-axis to BuC=100% and 50 000 CFU/ml E. coli =0% for the humoral marker IL-6 (the IL-6 values were multiplied by −1 before EC 50 calculation to facilitate comparability with the CRC) and the change in neutrophil phenotype represented by CD11b CRC. BuC indicates buffer control after 60 min incubation; numbers on the X-axis of c indicate E. coli bacteria in concentrations of 2000 to 50 000 CFU/ml after 60 min incubation. Values are shown as median and interquartile range. n =8. Statistical analysis was performed using the Kruskal-Wallis test with Dunn’s post-hoc test, evaluating the EC 50 of IL-8, MMP9, the MFI, and CRC of CD10, CD11b, and CD62L in comparison to the EC 50 of IL-6. P -values are indicated above the respective data points. ⁎ P <0.05. CFU. Colony-forming units; IL. Interleukin; MMP9. Matrix metallopeptidase 9.
Techniques Used: Diagnostic Assay, Fluorescence, Comparison, Concentration Assay, Marker, Control, Incubation, Bacteria
Figure Legend Snippet: Clinical specifications and parameters over all time points of the sepsis cohort. a Suspected infection cause of sepsis. b Distribution of the individual score points of the Sequential Organ Failure Assessment (SOFA) score. c Total SOFA score. d-h Traditional and humoral markers of inflammation: leukocytes and neutrophil-lymphocyte ratio ( d ), C-reactive protein (CRP) and procalcitonin (PCT) ( e ), interleukin-6 (IL-6) and interleukin-8 (IL-8) ( f ), serum amyloid A (SAA) and calprotectin ( g ), matrix metallopeptidase 9 (MMP9) and myeloperoxidase (MPO) ( h ). Values are shown as median and interquartile range. n =14. CNS. Central nervous system; HV. Healthy volunteers.
Techniques Used: Infection
Related Articles
Recombinant:Article Title: Metformin Directly Binds to MMP-9 to Improve Plaque Stability. Article Snippet: Experiments were performed at 25 ◦C using a Biacore T200, and the data were analyzed using Biacore T200 evaluation software 2.0 (GE Healthcare, Stockholm, Sweden). .. Article Title: AdhMMP8 Vector Administration in Muscle: An Alternate Strategy to Regress Hepatic Fibrosis. Article Snippet: .. This DuoSet was calibrated against a highly purified NS0-expressed recombinant Article Title: AdhMMP8 Vector Administration in Muscle: An Alternate Strategy to Regress Hepatic Fibrosis Article Snippet: .. This DuoSet was calibrated against a highly purified NS0-expressed recombinant Enzyme-linked Immunosorbent Assay:Article Title: aMMP-8 and MMP-9: Potential Biomarkers for periodontitis Progression in Patients Receiving Radiotherapy for Head and Neck Carcinoma Article Snippet: .. The concentrations of the total MMP-8 and -9, and IL-6 in the mouthrinse samples were detected using a commercially available enzyme-linked immunosorbent assay (ELISA) kit, following the manufacturer’s instructions ( Article Title: Methods of determining whether a subject has or is at risk of having a central serous chorioretinopathy Article Snippet: .. LCN2 and NGAL/MMP9 Serum Levels Measurements Human Lipocalin-2/NGAL Quantikine ELISA Kit and Purification:Article Title: AdhMMP8 Vector Administration in Muscle: An Alternate Strategy to Regress Hepatic Fibrosis. Article Snippet: .. This DuoSet was calibrated against a highly purified NS0-expressed recombinant Article Title: AdhMMP8 Vector Administration in Muscle: An Alternate Strategy to Regress Hepatic Fibrosis Article Snippet: .. This DuoSet was calibrated against a highly purified NS0-expressed recombinant Produced:Article Title: AdhMMP8 Vector Administration in Muscle: An Alternate Strategy to Regress Hepatic Fibrosis. Article Snippet: .. This DuoSet was calibrated against a highly purified NS0-expressed recombinant Article Title: AdhMMP8 Vector Administration in Muscle: An Alternate Strategy to Regress Hepatic Fibrosis Article Snippet: .. This DuoSet was calibrated against a highly purified NS0-expressed recombinant Concentration Assay:Article Title: NOTCH1: A Novel Player in the Molecular Crosstalk Underlying Articular Chondrocyte Protection by Oleuropein and Hydroxytyrosol Article Snippet: .. Then, the detection step was started with Article Title: NOTCH1: A Novel Player in the Molecular Crosstalk Underlying Articular Chondrocyte Protection by Oleuropein and Hydroxytyrosol. Article Snippet: .. Then, the detection step was started with Incubation:Article Title: NOTCH1: A Novel Player in the Molecular Crosstalk Underlying Articular Chondrocyte Protection by Oleuropein and Hydroxytyrosol Article Snippet: .. Then, the detection step was started with Article Title: NOTCH1: A Novel Player in the Molecular Crosstalk Underlying Articular Chondrocyte Protection by Oleuropein and Hydroxytyrosol. Article Snippet: .. Then, the detection step was started with |